{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:51:18Z","timestamp":1790171478558,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001027","name":"Department of Health and Ageing, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["568985"],"award-info":[{"award-number":["568985"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.drugpo.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T15:47:16Z","timestamp":1422114436000},"page":"992-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia"],"prefix":"10.1016","volume":"26","author":[{"given":"Carla","family":"Treloar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Rance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Bath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Everingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Hazelwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S2","key":"10.1016\/j.drugpo.2015.01.005_bib0005","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/cid\/cit305","article-title":"Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opiate substitution setting: The ETHOS study","volume":"57","author":"Alavi","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1016\/j.drugpo.2015.01.005_bib0010","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/MEG.0000000000000150","article-title":"Delivery of treatment for hepatitis C virus infection in the primary care setting","volume":"26","author":"Baker","year":"2014","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"S2","key":"10.1016\/j.drugpo.2015.01.005_bib0015","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/cid\/cit271","article-title":"Models of care for the management of HCV among people who use drugs: One size does not fit all","volume":"57","author":"Bruggmann","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/j.drugpo.2015.01.005_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1523-5394.1998.006003191.x","article-title":"Culturally relevant \u201cnavigator\u201d patient support the native sisters","volume":"6","author":"Burhansstipanov","year":"1998","journal-title":"Cancer Practice"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0025","first-page":"243","article-title":"Hepatitis C virus therapy update 2013","volume":"29","author":"Casey","year":"2013","journal-title":"Current Opinion in Gastroenterology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.01.005_bib0165","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.drugpo.2013.07.004","article-title":"Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic","volume":"24","author":"Crawford","year":"2013","journal-title":"International Journal of Drug Policy"},{"issue":"S2","key":"10.1016\/j.drugpo.2015.01.005_bib0035","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/cid\/cit297","article-title":"Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection","volume":"57","author":"Crawford","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.drugpo.2006.02.010","article-title":"The chronotope of the queue: Methadone maintenance treatment and the production of time, space and subjects","volume":"17","author":"Fraser","year":"2006","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/009145090603300406","article-title":"Speaking addictions: Substitution, metaphor and authenticity in newspaper representations of methadone treatment","volume":"33","author":"Fraser","year":"2006","journal-title":"Contemporary Drug Problems"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0050","series-title":"Substance and substitution: Methadone subjects in liberal societies","author":"Fraser","year":"2008"},{"issue":"5","key":"10.1016\/j.drugpo.2015.01.005_bib0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.drugpo.2007.03.003","article-title":"Education by peers is key to success","volume":"18","author":"Galindo","year":"2007","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2014.01.002","article-title":"Can hepatitis C virus infection be eradicated in people who inject drugs?","volume":"104","author":"Grebely","year":"2014","journal-title":"Antiviral Research"},{"issue":"3","key":"10.1016\/j.drugpo.2015.01.005_bib0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MEG.0b013e32832a8c4c","article-title":"Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: A novel model incorporating multidisciplinary care and peer support","volume":"22","author":"Grebely","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"6","key":"10.1016\/j.drugpo.2015.01.005_bib0070","first-page":"501","article-title":"Management of HCV and HIV infections among people who inject drugs","volume":"6","author":"Grebely","year":"2011","journal-title":"Current Opinions in HIV\/AIDS"},{"issue":"6","key":"10.1016\/j.drugpo.2015.01.005_bib0075","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: Institutionalized stigma and the prospect of recovery","volume":"22","author":"Harris","year":"2012","journal-title":"Qualitative Health Research"},{"issue":"1","key":"10.1016\/j.drugpo.2015.01.005_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/ADM.0b013e3181add3de","article-title":"Successful integration of hepatitis C evaluation and treatment services with methadone maintenance","volume":"4","author":"Harris","year":"2010","journal-title":"Journal of Addiction Medicine"},{"issue":"10","key":"10.1016\/j.drugpo.2015.01.005_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5694\/j.1326-5377.2009.tb03300.x","article-title":"The role of general practitioners in managing and treating hepatitis C","volume":"191","author":"Hellard","year":"2009","journal-title":"Medical Journal of Australia"},{"issue":"12","key":"10.1016\/j.drugpo.2015.01.005_bib0090","first-page":"900","article-title":"Under the watchful eye of \u2018a benevolent dictator\u2019: General practitioner and patient experiences of hepatitis C treatment initiation","volume":"42","author":"Hopwood","year":"2013","journal-title":"Australian Family Physician"},{"issue":"5","key":"10.1016\/j.drugpo.2015.01.005_bib0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2008.10.005","article-title":"Foucault on methadone: Beyond biopower","volume":"20","author":"Keane","year":"2009","journal-title":"International Journal of Drug Policy"},{"issue":"8","key":"10.1016\/j.drugpo.2015.01.005_bib0100","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/cid\/cis1202","article-title":"Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting","volume":"56","author":"Lloyd","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1016\/j.drugpo.2015.01.005_bib0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/mja12.11481","article-title":"Liver cancer is the fastest increasing cause of cancer death in Australians","volume":"197","author":"MacLachlan","year":"2012","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0110","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1525-1497.2005.0161.x","article-title":"Barriers to the treatment of hepatitis C: Patient, provider and system factors","volume":"20","author":"Morrill","year":"2005","journal-title":"Journal of General Internal Medicine"},{"issue":"8","key":"10.1016\/j.drugpo.2015.01.005_bib0115","article-title":"The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users","volume":"5","author":"Norman","year":"2008","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"10.1016\/j.drugpo.2015.01.005_bib0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/add.12392","article-title":"\u2018Not just Methadone Tracy\u2019: Transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings","volume":"109","author":"Rance","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1472-6963-13-168","article-title":"A systematic approach to the planning, implementation, monitoring, and evaluation of integrated health services","volume":"13","author":"Reynolds","year":"2013","journal-title":"BMC Health Services Research"},{"issue":"2","key":"10.1016\/j.drugpo.2015.01.005_bib0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1353\/hpu.2014.0096","article-title":"Reducing barriers to hepatitis C treatment among drug users: An integrated hepatitis C peer education and support program","volume":"25","author":"Roose","year":"2014","journal-title":"Journal of Health Care for the Poor and Underserved"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0376-8716(02)00010-8","article-title":"Treating hepatitis C in methadone maintenance patients: An interim analysis","volume":"67","author":"Sylvestre","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.drugpo.2015.01.005_bib0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drugpo.2007.01.010","article-title":"Integrating HCV services for drug users: A model to improve engagement and outcomes","volume":"18","author":"Sylvestre","year":"2007","journal-title":"International Journal of Drug Policy"},{"issue":"8","key":"10.1016\/j.drugpo.2015.01.005_bib0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3109\/10826084.2010.540289","article-title":"Evaluation of consumer participation demonstration projects in five Australian drug treatment facilities: The impact of individual versus organisational stability as determining factors of project progress","volume":"46","author":"Treloar","year":"2011","journal-title":"Substance Use and Misuse"},{"issue":"113","key":"10.1016\/j.drugpo.2015.01.005_bib0150","first-page":"8","article-title":"Patient navigation: State of the art, or is it science?","volume":"15","author":"Wells","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.drugpo.2015.01.005_bib0155","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/j.1743-7563.2012.01532.x","article-title":"Navigating the cancer journey: A review of patient navigator programs for Indigenous cancer patients","volume":"8","author":"Whop","year":"2012","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"key":"10.1016\/j.drugpo.2015.01.005_bib0160","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.drugpo.2013.05.018","article-title":"It gives me a sense of belonging: Providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group","volume":"24","author":"Wollhouse","year":"2013","journal-title":"International Journal of Drug Policy"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395915000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395915000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T22:54:12Z","timestamp":1668725652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395915000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0955395915000080"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.01.005","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}